Aevi Genomic Medicine, Inc. (GNMX)


Stock Price Forecast

Feb. 3, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Aevi Genomic Medicine, Inc. chart...

About the Company

Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engages in finding treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.

Sector

Health Technology

Industry

Biotechnology

Employees

14

Exchange

NASDAQ

Website

http://www.aevigenomics.com

$M

Total Revenue

14

Employees

$11M

Market Capitalization

-0.57

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $GNMX News

We don't have any news on Aevi Genomic Medicine, Inc. at the moment.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...